Bengaluru, India

Santhosh Kumar Madathil

This inventor holds 4 USPTO granted patents. Top assignee: Wipro Limited. Active years: 2017-2019.


% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2017-2019

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Santhosh Kumar Madathil

Introduction

Santhosh Kumar Madathil is an accomplished inventor based in Bengaluru, India. He has made significant contributions to the field of medical technology, particularly in drug adherence monitoring. With a total of 4 patents to his name, his work is paving the way for advancements in clinical trials and patient care.

Latest Patents

One of his latest patents is a monitoring device and a method of monitoring drug adherence in a clinical trial. This innovative device determines whether an authenticated user has consumed the medication and verifies their association with the corresponding monitoring device. It further assesses whether the drug has successfully passed through the gastrointestinal (GI) tract of the user by analyzing biometric signatures. The device reports successful drug adherence based on these determinations, ensuring that only the authenticated user is recognized as having consumed the medication.

Career Highlights

Santhosh Kumar Madathil is currently employed at Wipro Limited, where he continues to develop groundbreaking technologies. His expertise in biometric authentication and monitoring devices has positioned him as a key player in the medical technology sector.

Collaborations

He has collaborated with notable colleagues, including Yateesh S Kumar and Vijay A Kumar, to enhance the impact of his innovations.

Conclusion

Santhosh Kumar Madathil's contributions to drug adherence monitoring exemplify the intersection of technology and healthcare. His innovative patents are set to improve clinical trial processes and patient outcomes significantly.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…